Charan Leng

537 total citations · 1 hit paper
5 papers, 199 citations indexed

About

Charan Leng is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Charan Leng has authored 5 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Charan Leng's work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (3 papers) and Immune cells in cancer (3 papers). Charan Leng is often cited by papers focused on Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (3 papers) and Immune cells in cancer (3 papers). Charan Leng collaborates with scholars based in United States. Charan Leng's co-authors include Olga Burenkova, Christine McCoy, Dalia Burzyn, Chang Ling Sia, Sriram Sathyanarayanan, Kelvin Zhang, Tong Zi, Su Chul Jang, Kyriakos D. Economides and Sushrut Kamerkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Science Advances.

In The Last Decade

Charan Leng

4 papers receiving 195 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

2022 190 citations Sushrut Kamerkar, Charan Leng et al. Science Advances profile →

Peers

Countries citing papers authored by Charan Leng

Since Specialization

Citations

This map shows the geographic impact of Charan Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charan Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charan Leng more than expected).

Fields of papers citing papers by Charan Leng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charan Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charan Leng. The network helps show where Charan Leng may publish in the future.

Co-authorship network of co-authors of Charan Leng

This figure shows the co-authorship network connecting the top 25 collaborators of Charan Leng. A scholar is included among the top collaborators of Charan Leng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charan Leng. Charan Leng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity breakdown → 2022 ·Science Advances ·Sushrut Kamerkar, Charan Leng, Olga Burenkova, Su Chul Jang, Christine McCoy, Kelvin Zhang, Kevin Dooley, (unknown), Tong Zi, Sílvia Sisó, William K. Dahlberg, Chang Ling Sia, Shil Patel, Karl Schmidt, Kyriakos D. Economides, Timothy Soos, Dalia Burzyn, Sriram Sathyanarayanan	190
2	842 Exosome mediated reprogramming of tumor associated macrophages by exoASO-STAT6 for the treatment of hepatocellular carcinoma (HCC) 2021 ·SHILAP Revista de lepidopterología ·Sushrut Kamerkar, Charan Leng, Kelvin Zhang, Olga Burenkova, Su Chul Jang, (unknown), Tong Zi, Kyriakos D. Economides, Timothy Soos, Dalia Burzyn, (unknown)	0
3	Abstract 1792: Engineered exosome- mediated STAT6 knockdown in tumor associated macrophages (TAMs) results in potent single agent activity in a hepatocellular carcinoma (HCC) model 2021 ·Cancer Research ·Sushrut Kamerkar, Charan Leng, Olga Burenkova, Su Chul Jang, Christine McCoy, Kelvin Zhang, William K. Dahlberg, (unknown), (unknown), Sylvie Maubant, Olivier Duchamp, Kyriakos D. Economides, Timothy Soos, Dalia Burzyn, Sriram Sathyanarayanan	4
4	Abstract A50: Reprogramming of tumor-associated M2 macrophages with antisense oligonucleotide-loaded exosomes results in potent single-agent antitumor activity 2020 ·Cancer Immunology Research ·(unknown), Dalia Burzyn, Charan Leng, Olga Burenkova, Su Chul Jang, Raymond S. H. Yang, Adam T. Boutin, Katherine Kirwin, Tong Zi, William K. Dahlberg, Eric Zhang, Kelvin Zhang, Scott Estes, Kyriakos D. Economides, Timothy Soos, Sriram Sathyanarayanan	4
5	703 Engineered exosomes with altered cellular tropism achieve targeted STING agonist delivery and single-agent tumor control in vivo 2020 ·SHILAP Revista de lepidopterología ·Monique J. Kauke, Nikki L. Ross, Dalia Burzyn, (unknown), Ke Xu, Nuruddeen D. Lewis, Charan Leng, Su Chul Jang, Christine McCoy, Stephanie Yu, Kevin Dooley, Sriram Sathyanarayanan, Jonathan D. Finn	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact